Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
09 Feb 2024
Historique:
received: 21 12 2022
accepted: 31 01 2024
medline: 10 2 2024
pubmed: 10 2 2024
entrez: 9 2 2024
Statut: epublish

Résumé

The peripheral immune system is important in neurodegenerative diseases, both in protecting and inflaming the brain, but the underlying mechanisms remain elusive. Alzheimer's Disease is commonly preceded by a prodromal period. Here, we report the presence of large Aβ aggregates in plasma from patients with mild cognitive impairment (n = 38). The aggregates are associated with low level Alzheimer's Disease-like brain pathology as observed by

Identifiants

pubmed: 38336934
doi: 10.1038/s41467-024-45627-y
pii: 10.1038/s41467-024-45627-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1224

Subventions

Organisme : Aarhus Universitets Forskningsfond (Aarhus University Research Foundation)
ID : AUFF-E-2015-FLS-9-6
Organisme : Aarhus Universitets Forskningsfond (Aarhus University Research Foundation)
ID : AU IDEAS 2013
Organisme : Aarhus Universitets Forskningsfond (Aarhus University Research Foundation)
ID : AUFF-E-2015-FLS-9-6
Organisme : Aarhus Universitets Forskningsfond (Aarhus University Research Foundation)
ID : AU IDEAS 2013
Organisme : Aarhus Universitets Forskningsfond (Aarhus University Research Foundation)
ID : AU IDEAS 2013
Organisme : Novo Nordisk Fonden (Novo Nordisk Foundation)
ID : NNF19OC0058516
Organisme : Novo Nordisk Fonden (Novo Nordisk Foundation)
ID : NNF19OC0058516
Organisme : Novo Nordisk Fonden (Novo Nordisk Foundation)
ID : NNF21OC0071574
Organisme : Lundbeckfonden (Lundbeck Foundation)
ID : R380-2021-1326
Organisme : Lundbeckfonden (Lundbeck Foundation)
ID : R380-2021-1326
Organisme : Det Frie Forskningsråd (Danish Council for Independent Research)
ID : 2030-00002B
Organisme : Det Frie Forskningsråd (Danish Council for Independent Research)
ID : 3101-00104B
Organisme : Det Frie Forskningsråd (Danish Council for Independent Research)
ID : 2030-00002B
Organisme : Det Frie Forskningsråd (Danish Council for Independent Research)
ID : 4004-00305
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 European Institute of Innovation and Technology (H2020 The European Institute of Innovation and Technology)
ID : 820636
Organisme : Danmarks Grundforskningsfond (Danish National Research Foundation)
ID : DNRF135

Informations de copyright

© 2024. The Author(s).

Références

Heneka, M. T. et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 14, 388–405 (2015).
pubmed: 25792098 pmcid: 5909703 doi: 10.1016/S1474-4422(15)70016-5
Bettcher, B. M., Tansey, M. G., Dorothee, G. & Heneka, M. T. Peripheral and central immune system crosstalk in Alzheimer disease—a research prospectus. Nat. Rev. Neurol. 17, 689–701 (2021).
pubmed: 34522039 pmcid: 8439173 doi: 10.1038/s41582-021-00549-x
Cummings, J. et al. Lecanemab: appropriate use recommendations. J. Prev. Alzheimers Dis. 10, 362–377 (2023).
pubmed: 37357276 pmcid: 10313141
Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183–194 (2004).
pubmed: 15324362 doi: 10.1111/j.1365-2796.2004.01388.x
Parbo, P. et al. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s disease. Brain 140, 2002–2011 (2017).
pubmed: 28575151 doi: 10.1093/brain/awx120
Parbo, P. et al. Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease. Alzheimers Res. Ther. 12, 3 (2020).
pubmed: 31898549 pmcid: 6941285 doi: 10.1186/s13195-019-0574-0
Veitch, D. P. et al. Using the Alzheimer’s Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer’s disease. Alzheimers Dement 18, 824–857 (2022).
pubmed: 34581485 doi: 10.1002/alz.12422
Aksnes, M. et al. Serum amyloidogenic nanoplaques and cytokines in Alzheimer’s disease: pilot study in a small naturalistic memory clinic cohort. J. Alzheimers Dis. 86, 1459–1470 (2022).
pubmed: 35213378 pmcid: 9108575 doi: 10.3233/JAD-215504
Tiiman, A. et al. Amyloidogenic nanoplaques in blood serum of patients with Alzheimer’s disease revealed by time-resolved thioflavin T fluorescence intensity fluctuation analysis. J. Alzheimers Dis. 68, 571–582 (2019).
pubmed: 30814355 pmcid: 6484272 doi: 10.3233/JAD-181144
Teunissen, C. E. et al. Blood-based biomarkers for Alzheimer’s disease: towards clinical implementation. Lancet Neurol. 21, 66–77 (2022).
pubmed: 34838239 doi: 10.1016/S1474-4422(21)00361-6
De, S. et al. Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression. Acta Neuropathol. Commun. 7, 120 (2019).
pubmed: 31349874 pmcid: 6659275 doi: 10.1186/s40478-019-0777-4
Stern, A. M. et al. Abundant Abeta fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer’s disease brains. Neuron 111, 2012–2020.e2014 (2023).
pubmed: 37167969 doi: 10.1016/j.neuron.2023.04.007
Luo, J., Thomassen, J. Q., Nordestgaard, B. G., Tybjaerg-Hansen, A. & Frikke-Schmidt, R. Blood leukocyte counts in Alzheimer disease. JAMA Netw. Open 5, e2235648 (2022).
pubmed: 36215071 pmcid: 9552891 doi: 10.1001/jamanetworkopen.2022.35648
Terkelsen, M. H. et al. Neuroinflammation and immune changes in prodromal Parkinson’s disease and other synucleinopathies. J. Parkinsons Dis. 12, S149–S163 (2022).
pubmed: 35723115 pmcid: 9535563 doi: 10.3233/JPD-223245
Kapellos, T. S. et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 10, 2035 (2019).
pubmed: 31543877 pmcid: 6728754 doi: 10.3389/fimmu.2019.02035
Munoz-Castro, C. et al. Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus. Acta Neuropathol. Commun. 11, 31 (2023).
pubmed: 36855152 pmcid: 9976401 doi: 10.1186/s40478-023-01530-z
Saiga, R. et al. Brain capillary structures of schizophrenia cases and controls show a correlation with their neuron structures. Sci. Rep. 11, 11768 (2021).
pubmed: 34083657 pmcid: 8175464 doi: 10.1038/s41598-021-91233-z
Kucharz, K. et al. Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles. Nat. Commun. 12, 4121 (2021).
pubmed: 34226541 pmcid: 8257611 doi: 10.1038/s41467-021-24323-1
Erickson, M. A. & Banks, W. A. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer’s disease. J. Cereb. Blood Flow. Metab. 33, 1500–1513 (2013).
pubmed: 23921899 pmcid: 3790938 doi: 10.1038/jcbfm.2013.135
Pietronigro, E., Zenaro, E. & Constantin, G. Imaging of leukocyte trafficking in Alzheimer’s disease. Front Immunol. 7, 33 (2016).
pubmed: 26913031 pmcid: 4753285 doi: 10.3389/fimmu.2016.00033
Wilson, M. R., Satapathy, S. & Vendruscolo, M. Extracellular protein homeostasis in neurodegenerative diseases. Nat. Rev. Neurol. 19, 235–245 (2023).
pubmed: 36828943
Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301–314 (1994).
pubmed: 7507411 doi: 10.1016/0092-8674(94)90337-9
Davis, S. J., Ikemizu, S., Wild, M. K. & van der Merwe, P. A. CD2 and the nature of protein interactions mediating cell-cell recognition. Immunol. Rev. 163, 217–236 (1998).
pubmed: 9700513 doi: 10.1111/j.1600-065X.1998.tb01199.x
Vorup-Jensen, T. & Jensen, R. K. Structural immunology of complement receptors 3 and 4. Front Immunol. 9, 2716 (2018).
pubmed: 30534123 pmcid: 6275225 doi: 10.3389/fimmu.2018.02716
Vorup-Jensen, T. et al. Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin alphaXbeta2. Proc. Natl Acad. Sci. USA 102, 1614–1619 (2005).
pubmed: 15665082 pmcid: 547869 doi: 10.1073/pnas.0409057102
Simard, A. R., Soulet, D., Gowing, G., Julien, J. P. & Rivest, S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer’s disease. Neuron 49, 489–502 (2006).
pubmed: 16476660 doi: 10.1016/j.neuron.2006.01.022
Czirr, E. et al. Microglial complement receptor 3 regulates brain Abeta levels through secreted proteolytic activity. J. Exp. Med. 214, 1081–1092 (2017).
pubmed: 28298456 pmcid: 5379986 doi: 10.1084/jem.20162011
Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712–716 (2016).
pubmed: 27033548 pmcid: 5094372 doi: 10.1126/science.aad8373
Juul-Madsen, K. et al. Size-selective phagocytic clearance of fibrillar alpha-synuclein through conformational activation of complement receptor 4. J. Immunol. 204, 1345–1361 (2020).
pubmed: 31969389 doi: 10.4049/jimmunol.1900494
Akiyama, H. & McGeer, P. L. Brain microglia constitutively express beta-2 integrins. J. Neuroimmunol. 30, 81–93 (1990).
pubmed: 1977769 doi: 10.1016/0165-5728(90)90055-R
Juul-Madsen, K. et al. Characterization of DNA-protein complexes by nanoparticle tracking analysis and their association with systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 118, e2106647118 (2021).
pubmed: 34301873 pmcid: 8325352 doi: 10.1073/pnas.2106647118
Gjelstrup, L. C. et al. The role of nanometer-scaled ligand patterns in polyvalent binding by large mannan-binding lectin oligomers. J. Immunol. 188, 1292–1306 (2012).
pubmed: 22219330 doi: 10.4049/jimmunol.1103012
Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523–527 (1995).
pubmed: 7845465 doi: 10.1038/373523a0
Ziegler-Heitbrock, L. Blood monocytes and their subsets: established features and open questions. Front Immunol. 6, 423 (2015).
pubmed: 26347746 pmcid: 4538304 doi: 10.3389/fimmu.2015.00423
Segre, G. & Silberberg, A. Radial particle displacements in poiseuille flow of suspensions. Nature 189, 209 (1961).
doi: 10.1038/189209a0
Hansen, C. et al. Numerical simulation of LDL transport through the carotid arterial wall. Comput. Methods Biomech. Biomed. Eng. 17, 20–21 (2014).
doi: 10.1080/10255842.2014.931074
Kock, S. A. et al. Mechanical stresses in carotid plaques using MRI-based fluid-structure interaction models. J. Biomech. 41, 1651–1658 (2008).
pubmed: 18485351 doi: 10.1016/j.jbiomech.2008.03.019
Thrysøe, S. A. et al. Longitudinal distribution of mechanical stresses in carotid plaques of symptomatic patients. Stroke 41, 1041–1043 (2010).
pubmed: 20224059 doi: 10.1161/STROKEAHA.109.571588
Niemann, A. K. et al. Can sites prone to flow induced vascular complications in a-v fistulas be assessed using computational fluid dynamics? J. Biomech. 43, 2002–2009 (2010).
pubmed: 20382386 doi: 10.1016/j.jbiomech.2010.02.037
Kollmer, M. et al. Cryo-EM structure and polymorphism of Abeta amyloid fibrils purified from Alzheimer’s brain tissue. Nat. Commun. 10, 4760 (2019).
pubmed: 31664019 pmcid: 6820800 doi: 10.1038/s41467-019-12683-8
Vorup-Jensen, T. On the roles of polyvalent binding in immune recognition: perspectives in the nanoscience of immunology and the immune response to nanomedicines. Adv. Drug Deliv. Rev. 64, 1759–1781 (2012).
pubmed: 22705545 doi: 10.1016/j.addr.2012.06.003
Weetall, M. et al. A homogeneous fluorometric assay for measuring cell adhesion to immobilized ligand using V-well microtiter plates. Anal. Biochem 293, 277–287 (2001).
pubmed: 11399044 doi: 10.1006/abio.2001.5140
Gorshkova, I. I., Svitel, J., Razjouyan, F. & Schuck, P. Bayesian analysis of heterogeneity in the distribution of binding properties of immobilized surface sites. Langmuir 24, 11577–11586 (2008).
pubmed: 18816013 pmcid: 2574969 doi: 10.1021/la801186w
Svitel, J., Balbo, A., Mariuzza, R. A., Gonzales, N. R. & Schuck, P. Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria. Biophys. J. 84, 4062–4077 (2003).
pubmed: 12770910 pmcid: 1302986 doi: 10.1016/S0006-3495(03)75132-7
Bajic, G., Yatime, L., Sim, R. B., Vorup-Jensen, T. & Andersen, G. R. Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3. Proc. Natl Acad. Sci. USA 110, 16426–16431 (2013).
pubmed: 24065820 pmcid: 3799375 doi: 10.1073/pnas.1311261110
Tjernberg, L. O. et al. Amyloid beta-peptide polymerization studied using fluorescence correlation spectroscopy. Chem. Biol. 6, 53–62 (1999).
pubmed: 9889152 doi: 10.1016/S1074-5521(99)80020-9
Nielsen, M. A. et al. Galectin-3 decreases 4-1BBL bioactivity by crosslinking soluble and membrane expressed 4-1BB. Front. Immunol. 13, 915890 (2022).
pubmed: 35812455 pmcid: 9263355 doi: 10.3389/fimmu.2022.915890
Sevigny, J. et al. The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease. Nature 537, 50–56 (2016).
pubmed: 27582220 doi: 10.1038/nature19323
Kragstrup, T. W. et al. Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritis. Arthritis Res. Ther. 16, R42 (2014).
pubmed: 24490631 pmcid: 3978678 doi: 10.1186/ar4471
Stoy, S. et al. Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis. Clin. Transl. Gastroenterol. 9, 160 (2018).
pubmed: 29904132 pmcid: 6002386 doi: 10.1038/s41424-018-0022-7
Mohammad-Beigi, H. et al. Mapping and identification of soft corona proteins at nanoparticles and their impact on cellular association. Nat. Commun. 11, 4535 (2020).
pubmed: 32913217 pmcid: 7484794 doi: 10.1038/s41467-020-18237-7
Rustenhoven, J. et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184, 1000–1016.e1027 (2021).
pubmed: 33508229 pmcid: 8487654 doi: 10.1016/j.cell.2020.12.040
Rasmussen, M. K., Mestre, H. & Nedergaard, M. Fluid transport in the brain. Physiol. Rev. 102, 1025–1151 (2022).
pubmed: 33949874 doi: 10.1152/physrev.00031.2020
Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673–687 (2002).
pubmed: 12297042 doi: 10.1016/S0092-8674(02)00971-6
Miller, L. J., Bainton, D. F., Borregaard, N. & Springer, T. A. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J. Clin. Invest 80, 535–544 (1987).
pubmed: 3038962 pmcid: 442267 doi: 10.1172/JCI113102
Wang, X. et al. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors. Mol. Metab. 9, 57–68 (2018).
pubmed: 29396371 pmcid: 5870105 doi: 10.1016/j.molmet.2018.01.011
Ghirlando, R. et al. Improving the thermal, radial, and temporal accuracy of the analytical ultracentrifuge through external references. Anal. Biochem. 440, 81–95 (2013).
pubmed: 23711724 doi: 10.1016/j.ab.2013.05.011
Ma, J., Zhao, H., Sandmaier, J., Alexander Liddle, J. & Schuck, P. Variable field analytical ultracentrifugation: II. Gravitational sweep sedimentation velocity. Biophys. J. 110, 103–112 (2016).
pubmed: 26745414 pmcid: 4805870 doi: 10.1016/j.bpj.2015.11.027
Zhao, H., Brautigam, C. A., Ghirlando, R. & Schuck, P. Overview of current methods in sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation. Curr. Protoc. Protein Sci. Chapter 20, 12 (2013). Unit20.
Schuck, P. Sedimentation Velocity Analytical Ultracentrifugation: Discrete Species and Size-Distributions of Macromolecules and Particles (CRC Press, Taylor & Francis Group, 2016).
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).
pubmed: 22930834 pmcid: 5554542 doi: 10.1038/nmeth.2089
Aubert-Broche, B. et al. A new method for structural volume analysis of longitudinal brain MRI data and its application in studying the growth trajectories of anatomical brain structures in childhood. Neuroimage 82, 393–402 (2013).
pubmed: 23719155 doi: 10.1016/j.neuroimage.2013.05.065
Eskildsen, S. F. & Ostergaard, L. R. Active surface approach for extraction of the human cerebral cortex from MRI. Med. Image Comput. Comput. Assist Inter. 9, 823–830 (2006).
Lerch, J. P. & Evans, A. C. Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage 24, 163–173 (2005).
pubmed: 15588607 doi: 10.1016/j.neuroimage.2004.07.045
Jack, C. R. Jr et al. Defining imaging biomarker cut points for brain aging and Alzheimer’s disease. Alzheimers Dement 13, 205–216 (2017).
pubmed: 27697430 doi: 10.1016/j.jalz.2016.08.005
Ivanov, K. P., Kalinina, M. K. & Levkovich Yu, I. Blood flow velocity in capillaries of brain and muscles and its physiological significance. Microvasc. Res. 22, 143–155 (1981).
Alateeq, K., Walsh, E. I., Abhayaratna, W. P. & Cherbuin, N. Effects of higher normal blood pressure on brain are detectable before middle-age and differ by sex. J. Clin. Med 11, 3127 (2022).
pubmed: 35683516 pmcid: 9181456 doi: 10.3390/jcm11113127
Wedel, J., Štrakl, M., Ravnik, J., Steinmann, P. & Hriberšek, M. A specific slip length model for the Maxwell slip boundary conditions in the Navier–Stokes solution of flow around a microparticle in the no-slip and slip flow regimes. Theor. Comput. Fluid Dyn. 36, 723–740 (2022).
doi: 10.1007/s00162-022-00627-w
Nader, E. et al. Blood Rheology: key parameters, impact on blood flow, role in sickle cell disease and effects of exercise. Front Physiol. 10, 1329 (2019).
pubmed: 31749708 pmcid: 6842957 doi: 10.3389/fphys.2019.01329
Stapulionis, R. et al. Structural insight into the function of myelin basic protein as a ligand for integrin alpha M beta 2. J. Immunol. 180, 3946–3956 (2008).
pubmed: 18322203 doi: 10.4049/jimmunol.180.6.3946
Vorup-Jensen, T. Surface plasmon resonance biosensing in studies of the binding between beta(2) integrin I domains and their ligands. Methods Mol. Biol. 757, 55–71 (2012).
pubmed: 21909906 doi: 10.1007/978-1-61779-166-6_5
McQuade, A. et al. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol. Neurodegener. 13, 67 (2018).
pubmed: 30577865 pmcid: 6303871 doi: 10.1186/s13024-018-0297-x

Auteurs

Kristian Juul-Madsen (K)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.
Max-Delbrueck-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125, Berlin, Germany.

Peter Parbo (P)

Department of Nuclear Medicine, Odense University Hospital, J. B. Winsløws Vej 4, DK-5000, Odense C, Denmark.

Rola Ismail (R)

Department of Nuclear medicine and PET, Vejle Hospital, Beriderbakken 4, DK-7100, Vejle, Denmark.

Peter L Ovesen (PL)

Max-Delbrueck-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125, Berlin, Germany.

Vanessa Schmidt (V)

Max-Delbrueck-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125, Berlin, Germany.

Lasse S Madsen (LS)

Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200, Aarhus N, Denmark.
Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, DK-8200, Aarhus N, Denmark.
Center of Functionally Integrative Neuroscience, Aarhus University and Aarhus University Hospital, Building 1710, Universitetsbyen 3, DK-8200, Aarhus C, Denmark.

Jacob Thyrsted (J)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.

Sarah Gierl (S)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.

Mihaela Breum (M)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.

Agnete Larsen (A)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.

Morten N Andersen (MN)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.
Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, DK-8200, Aarhus N, Denmark.
Department of Hematology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200, Aarhus N, Denmark.

Marina Romero-Ramos (M)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.
NEURODIN AU IDEAS Center, Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8200, Aarhus C, Denmark.

Christian K Holm (CK)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.

Gregers R Andersen (GR)

Department of Molecular Biology and Genetics, Aarhus University, Universitetsbyen 81, DK-8000, Aarhus C, Denmark.

Huaying Zhao (H)

Laboratory of Dynamics and Macromolecular Assembly, National Institute of Biomedical Imaging and Bioengineering, Building 31, 9000 Rockville Pike, Bethesda, MD, 20892, USA.

Peter Schuck (P)

Laboratory of Dynamics and Macromolecular Assembly, National Institute of Biomedical Imaging and Bioengineering, Building 31, 9000 Rockville Pike, Bethesda, MD, 20892, USA.

Jens V Nygaard (JV)

Department of Biological and Chemical Engineering, Aarhus University, Gustav Wieds vej 10 D, DK-8200, Aarhus C, Denmark.

Duncan S Sutherland (DS)

Interdisiciplinary Nanoscience Center, Aarhus University, The iNANO House, Gustav Wieds Vej 14, DK-8200, Aarhus C, Denmark.
Center for Cellular Signal Patterns, Aarhus University, The iNANO House, Gustav Wieds Vej 14, DK-8200, Aarhus C, Denmark.

Simon F Eskildsen (SF)

Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 11, DK-8200, Aarhus N, Denmark.
Center of Functionally Integrative Neuroscience, Aarhus University and Aarhus University Hospital, Building 1710, Universitetsbyen 3, DK-8200, Aarhus C, Denmark.

Thomas E Willnow (TE)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark.
Max-Delbrueck-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125, Berlin, Germany.

David J Brooks (DJ)

Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200, Aarhus N, Denmark.
Department of Brain Sciences, Imperial College London, Burlington Danes, The Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK.
Institute of Translational and Clinical Research, University of Newcastle, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.

Thomas Vorup-Jensen (T)

Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8000, Aarhus C, Denmark. vorup-jensen@biomed.au.dk.
NEURODIN AU IDEAS Center, Department of Biomedicine, Aarhus University, The Skou Building, Høegh-Guldbergs Gade 10, DK-8200, Aarhus C, Denmark. vorup-jensen@biomed.au.dk.
Interdisiciplinary Nanoscience Center, Aarhus University, The iNANO House, Gustav Wieds Vej 14, DK-8200, Aarhus C, Denmark. vorup-jensen@biomed.au.dk.

Classifications MeSH